Animal Vaccines Market Size, Share & Trends Report, 2028

Global Animal Vaccine Market Research Report: Forecast (2023-2028)

By Type (Porcine Vaccines, Aquaculture Vaccines, Ruminants Vaccines, Companion Animals Vaccines (Canine Vaccines, Feline Vaccines, Poultry Vaccines), Livestock Vaccines), By Diseases (Porcine Diseases... ... es (Porcine Diseases, Aquaculture Diseases, Ruminants Diseases, Companion Animals Diseases (Canine Diseases, Feline Diseases), Poultry Diseases, Livestock Diseases), By Technology (Live Attenuated Vaccines, Livestock Inactivated Vaccines, Toxoid Vaccine, Recombinant Vaccines, Others (DNA vaccines)), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa), By Competitors (Elanco, Ceva, Phibro Animal Health Corporation, Neogen Corporation, Intas Pharmaceuticals Ltd., Biogénesis Bagó, Ourofino Saúde Animal, Virbac, Zoetis, Merc & Co., Inc., Boehringer Ingelheim International GmbH) Read more

Healthcare
Feb 2023
Pages 276
Report Format: PDF, Excel, PPT

Market Definition

Animal Vaccines ensure the healthy state of the animal and reduce animal suffering. Additionally, vaccines enable the efficient production of animals to feed the expanding human population and eliminate the need for antibiotics.

Market Insights & Analysis: Global Animal Vaccines Market (2023-28)

The Global Animal Vaccines Market is projected to grow at a CAGR of around 7.4% during the forecast period, i.e., 2023-28. The constantly inflating livestock population paving the way for bursts of cattle disease has been the prime factor behind the wide acceptance of vaccines throughout the globe. Besides, the rising trend of pet ownership also increases awareness of domestic animals' health, propelling the market growth.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	7.4%
Regions Covered	North America: US, Canada
	Europe: Germany, The UK, France, Italy, Spain, Others
	Asia-Pacific: China, India, Japan, Thailand, Australia, Others
	South America: Brazil, Others
	Middle East & Africa: Saudi Arabia, UAE, South Africa, Others
Key Companies Profiled	Elanco, Ceva, Phibro Animal Health Corporation, Neogen Corporation, Intas Pharmaceuticals Ltd., Biogénesis Bagó, Ourofino Saúde Animal, Virbac, Zoetis, Merc & Co., Inc., Boehringer Ingelheim International GmbH, Others
Unit Denominations	USD Million/Billion

Various key players' investments, support, and funding have ensured an easy supply flow of animal vaccines to prevent zoonotic viruses from spreading into communities. As such, the escalating number of R&D investments initiated by governments & companies is another potential growth factor for the Global Animal Vaccine Market.

The market is anticipated to develop quickly in the Asia-Pacific during the projected period. India had 192.5 million cattle in 2019, up from 190.9 million in 2012, according to the National Dairy Development Board. Since so many cattle are in the nation, the need for vaccines is increasing gradually. In addition, the rising efforts to commercialize veterinary vaccines and inoculations at tolerably low prices drive the industry further.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
4. Market Segmentation
Preface
Executive Summary
Impact of COVID-19 on Global Animal Vaccines Market
Global Animal Vaccines Market Trends & Insights
Global Animal Vaccines Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Animal Vaccines Market Hotspot & Opportunities
Global Animal Vaccines Market Regulations and Policies
Global Animal Health Market Overview
Animal Vaccine Research & Development Process Map
Global Animal Vaccines Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Market Revenue (USD Million)
2. Market Share & Analysis
  1. By Type
    1. Porcine Vaccines
    2. Aquaculture Vaccines
    3. Ruminants Vaccines
    4. Companion Animals Vaccines
      1. Canine Vaccines
      2. Feline Vaccines
    5. Poultry Vaccines
    6. Livestock Vaccines
  2. By Diseases
    1. Porcine Diseases
    2. Aquaculture Diseases
    3. Ruminants Diseases
    4. Companion Animals Diseases
      1. Canine Diseases
      2. Feline Diseases
    5. Poultry Diseases
    6. Livestock Diseases
  3. By Technology
    1. Live Attenuated Vaccines
    2. Livestock Inactivated Vaccines
    3. Toxoid Vaccines
    4. Recombinant Vaccines
    5. Other (DNA vaccines)
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Asia Pacific
    5. Middle East and Africa
  5. By Competitors
    1. Competition Characteristics
    2. Market Share & Analysis
    3. Competitive Matrix
North America Animal Vaccines Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Market Revenue (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Diseases
  3. By Technology
  4. By Country
    1. The US
    2. Canada
3. The US Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
4. Canada Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
South America Animal Vaccines Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Market Revenue (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Diseases
  3. By Technology
  4. By Country
    1. Brazil
    2. Others
3. Brazil Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
Europe Animal Vaccines Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Market Revenue (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Diseases
  3. By Technology
  4. By Country
    1. Germany
    2. The UK
    3. France
    4. Italy
    5. Spain
    6. Others
3. Germany Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
4. The UK Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
5. France Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
6. Italy Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
7. Spain Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
Asia Pacific Animal Vaccines Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Market Revenue (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Diseases
  3. By Technology
  4. By Country
    1. China
    2. India
    3. Japan
    4. Thailand
    5. Australia
    6. Others
3. China Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
4. India Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
5. Japan Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
6. Thailand Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
7. Australia Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
Middle East & Africa Animal Vaccines Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Market Revenue (USD Million)
2. Market Share & Analysis
  1. By Type
  2. By Diseases
  3. By Technology
  4. By Country
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Others
3. Saudi Arabia Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
4. South Africa Animal Vaccines Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Market Revenue (USD Million)
  2. Market Share & Analysis
    1. By Type
Key Strategic Imperatives for Success and Growth
Competition Outlook (Whichever Applicable)
1. Competition Matrix
  1. Target Markets
  2. Research & Development
  3. Collaborations & Strategic Alliances
  4. Key Business Expansion Initiatives
  5. Business Restructuring – Mergers, Acquisitions, JVs
  6. Strategic Initiatives
2. Company Profiles (Business Description, Product Categories, Market Focused Product Category, Business Segments, Market Focused Business Segment, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Elanco
  2. Ceva
  3. Phibro Animal Health Corporation
  4. Neogen Corporation
  5. Intas Pharmaceuticals Ltd.
  6. Biogénesis Bagó
  7. Ourofino Saúde Animal
  8. Virbac
  9. Zoetis
  10. Merc & Co., Inc.
  11. Boehringer Ingelheim International GmbH
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying